Clinical Trials Directory

Trials / Completed

CompletedNCT05428774

Efficacy of Different Oral Rehydration Solutions on the Hydration Status of Healthy Males

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Liquid I.V. · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Dehydration lowers both physical and mental performance if it is severe enough. Performance declines are more pronounced in hot conditions or after prolonged strenuous activity such as exercise. Most individuals drink less than their sweat losses during activity, while some individuals overdrink and develop a sodium deficiency. Water and electrolyte balance must be restored as part of the recovery process after any activity that causes sweating. Plain water causes a decrease in plasma sodium concentration and osmolality, which reduces the desire to drink and increases urine production. Unless the volume ingested exceeds the loss, individuals are in net negative fluid balance throughout the recovery period due to urinary losses. When sodium and potassium are added to rehydration fluids, urine production is reduced in the hours following rehydration. Rehydration is only possible if a volume of fluid equal to or greater than the amount lost through sweat is consumed, together with adequate electrolytes. The two test products for this study, are novel hydration beverage formulas. They are an electrolyte drink mixture with five essential vitamins and three times more electrolytes than typical sports beverages. The test products create an osmotic force that permits water to be supplied to the bloodstream sooner in the digestive system by using a specific ratio of sodium, glucose, and potassium. This randomized, placebo-controlled, semi-blind, crossover study will evaluate the effects of the test products on rehydration in healthy adults.

Conditions

Interventions

TypeNameDescription
OTHERTest product 1Participants will receive TP1 during one experimental visit.
OTHERTest product 2Participants will receive TP2 during one experimental visit.
OTHERPlaceboParticipants will receive placebo during one experimental visit.

Timeline

Start date
2022-08-01
Primary completion
2022-11-01
Completion
2023-01-01
First posted
2022-06-23
Last updated
2023-01-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05428774. Inclusion in this directory is not an endorsement.